Hims & Hers Reports Q3 2026 Revenue Growth Amid Strategic Marketing Pullback
Hims & Hers (HIMS) reported third-quarter revenue of $890 million, representing a 49% year-over-year increase. Despite this growth, the company experienced a net decline of 100,000 subscribers, which management attributed to an intentional reduction in marketing spend designed to preserve capital and prepare for a major product catalog expansion ahead of peak seasonal demand in early 2027. The company is strategically positioning itself within the weight-loss market by securing access to branded GLP-1 treatments from Eli Lilly and Novo Nordisk. Additionally, Hims & Hers is focusing on international scaling, with revenue from the United Kingdom, Germany, and Australia reaching $233 million this quarter. Management expects international revenue to exceed a $1 billion run rate by 2027.
Topics: GLP-1 Expansion Marketing Strategy Revenue Growth Subscriber Metrics